StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.11−0.04 (-3.48%)

Close on Nov 18, 2026Market cap $80.25MP/E –Yield –

InflaRx cash

Cash and short-term investments held at the end of each period.

InflaRx's cash was €16.02M at Dec 31, 2025. For fiscal 2025 it was €16.02M, down 12.8% from the year before. Over ten years it grew 17.1% a year on average. The highest annual figure on record is €123.28M in fiscal 2017.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025€16.02M-12.8%
FY2024Dec 31, 2024€18.38M+43.9%
FY2023Dec 31, 2023€12.77M-21.5%
FY2022Dec 31, 2022€16.27M-38.0%
FY2021Dec 31, 2021€26.25M+1.1%
FY2020Dec 31, 2020€25.97M-21.6%
FY2019Dec 31, 2019€33.13M-40.2%
FY2018Dec 31, 2018€55.39M-55.1%
FY2017Dec 31, 2017€123.28M+323.4%
FY2016Dec 31, 2016€29.12M+781.8%
FY2015Dec 31, 2015€3.30M-50.1%
FY2014Dec 31, 2014€6.62M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025€16.02M+25.5%
Q2 FY2025Jun 30, 2025€13.00M-33.4%
Q4 FY2024Dec 31, 2024€18.38M+13.0%
Q2 FY2024Jun 30, 2024€19.15M+24.2%
Q4 FY2023Dec 31, 2023€12.77M-51.4%
Q2 FY2023Jun 30, 2023€19.52M-73.0%
Q4 FY2022Dec 31, 2022€16.27M-37.4%
Q2 FY2022Jun 30, 2022€15.42M-53.5%
Q4 FY2021Dec 31, 2021€26.25M-51.4%
Q2 FY2021Jun 30, 2021€72.36M+30.6%
Q4 FY2020Dec 31, 2020€25.97M-83.4%
Q4 FY2019Dec 31, 2019€33.13M-73.1%
Q2 FY2019Jun 30, 2019€54.06M+85.7%
Q4 FY2018Dec 31, 2018€55.39M+1577.4%
Q2 FY2018Jun 30, 2018€156.07M+2256.8%
Q4 FY2017Dec 31, 2017€123.28M–
Q4 FY2016Dec 31, 2016€29.12M–
Q4 FY2015Dec 31, 2015€3.30M–
Q4 FY2014Dec 31, 2014€6.62M–

More InflaRx figures

See a number that looks wrong?